Clinical Focus

  • Infectious Disease

Academic Appointments

Professional Education

  • Residency: University of South Florida Internal Medicine Residency Program FL
  • Fellowship: University of South Florida Infectious Diseases Fellowship FL
  • Board Certification: American Board of Internal Medicine, Infectious Disease (2019)
  • Board Certification: American Board of Internal Medicine, Internal Medicine (2017)
  • Medical Education: Edward Via College of Osteopathic Medicine (2014) VA

All Publications

  • Beyond the surface: a color-inclusive guide to central line site assessment. Antimicrobial stewardship & healthcare epidemiology : ASHE Herrera, M., Eichenblat, S., Campbell, E., Shick, J., Brown, H., Brinkley, C., Kester, S., Layell, J., Passaretti, C. L., Sampson, M. M. 2024; 4 (1): e41


    Significant gaps exist in representation of diverse populations in central-line assessment education and tools. We review some of these gaps and provide some real-world guidance on how to assess central line sites in patients of all skin tones.

    View details for DOI 10.1017/ash.2024.39

    View details for PubMedID 38628376

    View details for PubMedCentralID PMC11019580

  • Syphilis Treatment: Systematic Review and Meta-Analysis Investigating Nonpenicillin Therapeutic Strategies. Open forum infectious diseases Callado, G. Y., Gutfreund, M. C., Pardo, I., Hsieh, M. K., Lin, V., Sampson, M. M., Nava, G. R., Marins, T. A., Deliberato, R. O., Martino, M. D., Holubar, M., Salinas, J. L., Marra, A. R. 2024; 11 (4): ofae142


    Background: Penicillin's long-standing role as the reference standard in syphilis treatment has led to global reliance. However, this dependence presents challenges, prompting the need for alternative strategies. We performed a systematic literature review and meta-analysis to evaluate the efficacy of these alternative treatments against nonneurological syphilis.Methods: We searched MEDLINE, the Cumulative Index to Nursing and Allied Health Literature, Embase, Cochrane, Scopus, and Web of Science from database inception to 28 August 2023, and we included studies that compared penicillin or amoxicillin monotherapy to other treatments for the management of nonneurological syphilis. Our primary outcome was serological cure rates. Random-effect models were used to obtain pooled mean differences, and heterogeneity was assessed using the I2 test.Results: Of 6478 screened studies, 27 met the inclusion criteria, summing 6710 patients. The studies were considerably homogeneous, and stratified analyses considering each alternative treatment separately revealed that penicillin monotherapy did not outperform ceftriaxone (pooled odds ratio, 1.66 [95% confidence interval, .97-2.84]; I2 = 0%), azithromycin (0.92; [.73-1.18]; I2 = 0%), or doxycycline (0.82 [.61-1.10]; I2 = 1%) monotherapies with respect to serological conversion.Conclusions: Alternative treatment strategies have serological cure rates equivalent to penicillin, potentially reducing global dependence on this antibiotic.

    View details for DOI 10.1093/ofid/ofae142

    View details for PubMedID 38595955